Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Joaquín M Campos Juan Carlos Lacal |
| Publication date | December 8, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |